{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:16:08Z","timestamp":1790838968361,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.trsl.2009.12.003","type":"journal-article","created":{"date-parts":[[2009,12,31]],"date-time":"2009-12-31T09:17:11Z","timestamp":1262251031000},"page":"200-208","source":"Crossref","is-referenced-by-count":13,"title":["Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and\/or survival: observations from a case series"],"prefix":"10.1016","volume":"155","author":[{"given":"Alessandra","family":"Casonato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Gallinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Cattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sartorello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pontara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Padrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Bertomoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Daidone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pagnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2009.12.003_bib1","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand factor. The Working Party on von Willebrand disease classification","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2009.12.003_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1160\/TH07-04-0279","article-title":"Von Willebrand factor: looking back and looking forward","volume":"98","author":"Ruggeri","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2009.12.003_bib3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.V65.4.823.823","article-title":"Factor VIII\/von Willebrand factor in subendothelium mediates platelet adhesion","volume":"65","author":"Turitto","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2009.12.003_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Ann Rev Biochem"},{"key":"10.1016\/j.trsl.2009.12.003_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor","volume":"6","author":"Wagner","year":"1990","journal-title":"Ann Rev Cell Biol"},{"key":"10.1016\/j.trsl.2009.12.003_bib6","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand disease","volume":"302","author":"Ruggeri","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2009.12.003_bib7","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1073\/pnas.89.8.3531","article-title":"Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly","volume":"89","author":"Mayadas","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2009.12.003_bib8","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1172\/JCI109070","article-title":"Von Willebrand's disease antigen II: a new plasma and platelet antigen deficient in severe von Willebrand's disease","volume":"61","author":"Montgomery","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2009.12.003_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.95.1.355","article-title":"Immunolocalization of von Willebrand factor protein in Weibel-palade bodies of human endothelial cells","volume":"95","author":"Wagner","year":"1982","journal-title":"J Cell Biol"},{"key":"10.1016\/j.trsl.2009.12.003_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood.V94.1.179.413k18_179_185","article-title":"Von Willebrand factor propeptide in vascular disorders: a tool to distinguish between acute and chronic endothelial cell perturbation","volume":"94","author":"van Mourik","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2009.12.003_bib11","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V88.8.2951.bloodjournal8882951","article-title":"Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-desamino-8-D-arginine vasopressin in humans","volume":"88","author":"Borchiellini","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2009.12.003_bib12","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2009.12.003_bib13","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2009.12.003_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2141.2008.07311.x","article-title":"Von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease","volume":"143","author":"Sztukowska","year":"2008","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.trsl.2009.12.003_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1538-7836.2007.02488.x","article-title":"Type 1 von Willebrand disease","volume":"5","author":"Peake","year":"2007","journal-title":"J Thromb Haemosts"},{"key":"10.1016\/j.trsl.2009.12.003_bib16","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2009.12.003_bib17","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI109795","article-title":"Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII\/von Willebrand factor in plasma and platelets","volume":"65","author":"Ruggeri","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2009.12.003_bib18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V99.1.180","article-title":"Reduced von Willebrand factor survival in type Vicenza von Willebrand disease","volume":"99","author":"Casonato","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2009.12.003_bib19","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1046\/j.1538-7836.2003.00359.x","article-title":"Increased clearance of von Willebrand factor in type 1 von Willebrand disease: is it a potential pathogenetic process?","volume":"1","author":"Brown","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2009.12.003_bib20","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2007-08-109231","article-title":"Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD","volume":"111","author":"Castaman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2009.12.003_bib21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2009.12.003_bib22","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1365-2141.2001.02597.x","article-title":"Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin cofactor activity?","volume":"112","author":"Casonato","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2009.12.003_bib23","series-title":"Pharmacokinetics","author":"Gibaldi","year":"1975"},{"key":"10.1016\/j.trsl.2009.12.003_bib24","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1365-2141.1996.d01-1860.x","article-title":"Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis","volume":"94","author":"Menache","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2009.12.003_bib25","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"Mancuso","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2009.12.003_bib26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1055\/s-0037-1615770","article-title":"A standard nomenclature for von Willebrand factor gene mutations and polymorphisms. On behalf of the ISTH SSC Subcommittee on von Willebrand factor","volume":"85","author":"Goodeve","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2009.12.003_bib27","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood.V56.4.712.712","article-title":"Serial studies in von Willebrand's disease: variability versus variants","volume":"56","author":"Abildgaard","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2009.12.003_bib28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2141.2007.06907.x","article-title":"Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing's syndrome","volume":"140","author":"Casonato","year":"2008","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.trsl.2009.12.003_bib29","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2009.12.003_bib30","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-11-122945","article-title":"A shorter von Willebrand factor survival in O blood group explains how ABO determinants influence plasma von Willebrand factor","volume":"111","author":"Gallinaro","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2009.12.003_bib31","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1182\/blood-2002-04-1168","article-title":"ABO blood group influences the von Willebrand factor (VWF) antigen level in heterozygous carriers of VWF null alleles, type 2N Arg854Gln, and the missense mutation Cys2362Phe","volume":"100","author":"Castaman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2009.12.003_bib32","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1160\/TH07-09-0565","article-title":"Survival of von Willebrand factor released following DDAVP in type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations","volume":"99","author":"Millar","year":"2008","journal-title":"Thromb Haemost"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524409003508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524409003508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T18:17:51Z","timestamp":1634667471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524409003508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1931524409003508"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2009.12.003","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}